Edwin Charlebois, MPH, PhD
Prevention, epidemiology, testing, treatment policy, combination prevention, implementation science, surveillance, tuberculosis co-infection
Prevention, epidemiology, testing, treatment policy, combination prevention, implementation science, surveillance, tuberculosis co-infection
HIV Evolution, Pathogenesis, Systems Biology, CD4-Positive, T-Lymphocytes, HIV-1, Interferon-alpha
Antigens, Bacteria; Interferon-gamma, Tuberculosis, Mycobacterium TB, Pulmonary TB
HIV-1 and Hepatitis C Virus (HCV) Gene Expression Regulation, Viral; Hepacivirus, Virus Latency, Positive Transcriptional Elongation Factor B; tat Gene Products, Human Immunodeficiency Virus, Dengue and Zika Virus
Mucosal, Cytof, Amyloid, Chlamydia Infections, Semen, HIV-1, RNA Sequencing
HIV, HIV-1, HIV-2, HIV Infections, CD8-Positive T-Lymphocytes
AIDS vaccine, HIV, HIV-Infection, Recombinant Envelope Protein, HIV in Vitro, Collaborator at Genentech, Affordable vaccine
HIV-1, Semen, CD4-Positive T-Lymphocytes, HIV-1, NF-kappa B, Virus Latency, International, Mentoring Junior Faculty